A Retro94-based compound may prevent a common and sometimes fatal virus — human cytomegalovirus (CMV) — from reproducing and help to protect immunocompromised patients, such as those with HIV, on chemotherapy, with transplants, and infants from the effects of the disease, according to researchers.